Table 9 Probability of dropout due to primary ineffectiveness.

From: Real-world retention rates of biologics in patients with rheumatoid arthritis

 

ABT

TCZ

TNFi

p-value

Total

9/17 (52.9)

2/15 (13.3)

43/132 (32.6)

0.0579

Naïve

2/6 (33.3)

0/2 (0.0)

15/78 (19.2)

0.5480

  1. Data are shown as dropout due to primary ineffectiveness/total dropout (%).
  2. ABT abatacept, TCZ tocilizumab, TNFi tumor necrosis factor inhibitors.
Back to article page